AI analysis of CT scans finds 42.9% of patients have coronary inflammation (www.biograph.com)

Biograph has announced a significant advancement in cardiovascular health through the completion of its first U.S. study utilizing Caristo Diagnostics’ AI-powered CaRi-Heart® technology. This research reveals that a striking 42.9% of asymptomatic, low-risk adults exhibit coronary inflammation, a condition undetectable by standard blood tests and traditional cardiovascular risk assessments. By integrating high-resolution coronary computed tomography angiography (CCTA) imaging with AI diagnostics, the study highlights the prevalence of inflammation in heart arteries, even in individuals with no plaque buildup. The study's findings have profound implications for the AI/ML community and clinical practice, suggesting that traditional metrics such as cholesterol levels and systemic inflammation markers do not capture the complete picture of cardiovascular risk. With nearly half of participants without detectable plaque exhibiting elevated inflammation, these results challenge current assessment protocols and underscore the need for further research on this upstream phase of cardiovascular disease. By identifying and addressing coronary inflammation early, this innovative AI technology could pave the way for proactive interventions, offering a pivotal shift towards personalized healthcare in the prevention of heart disease.